Patents Assigned to GlaxoSmithKline Intellectual Property Development Ltd.
  • Patent number: 8399444
    Abstract: The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts or solvates thereof, processes for their preparation, pharmaceutical compositions containing these compounds, and their use in the treatment of allergic disorders, such as allergic rhinitis and asthma.
    Type: Grant
    Filed: December 16, 2009
    Date of Patent: March 19, 2013
    Assignee: GlaxoSmithKline Intellectual Property Development Ltd.
    Inventors: Ian Baxter Campbell, Simon Peace, John Martin Pritchard, Daniel Tape, Robert Charles Wheeler